Benchmark, the global aquaculture genetics, health and specialist nutrition firm, is coming off a radical year of restructuring, giving the group a new focus CEO Trond Williksen believes will lead to long-term growth.

At the start of 2020, Benchmark had come off a brutal year that saw it slide into red numbers, But while the figures weren't stellar for fiscal year 2020, the group's loss before tax from continuing operations of £2.9 million (€3.2 million/$3.9 million) was much narrower than the same quarter last year.